![Keith Wycoff](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Oorsprong van het eerstegraads netwerk van Keith Wycoff
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Seal Rock Therapeutics, Inc.
![]() Seal Rock Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Seal Rock Therapeutics, Inc. develops molecule inhibitors apoptosis, inflammation and fibrosis. The company was founded by Kathleen Elias, Neil McDonnell and Artur Plonowski is headquartered in Seattle, WA.
2
| Holding Company | Pharmaceuticals: Major | 2 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Keith Wycoff via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
Bill & Melinda Gates Foundation Trust
![]() Bill & Melinda Gates Foundation Trust Financial ConglomeratesFinance The Bill & Melinda Gates Foundation was formed in 1997 as the William H. Gates Foundation. In 1999, the foundation was renamed the Bill & Melinda Gates Foundation. The Bill & Melinda Gates Foundation Trust was created in January 2000 through the merger of the Gates Learning Foundation, which worked to expand access to technology through public libraries and the William H. Gates Foundation, which focused on improving global health. The foundation participates in preventive approaches and collaborative endeavors with government, philanthropic and not-for-profit partners. Priority is given to grants that leverage additional support and serve as a catalyst for long-term, systemic change. The foundation also provides funds to promote greater equity in global health, education and public libraries. Through their partnerships in communities across the US, the Bill & Melinda Gates Foundation is committed to raising the high school graduation rate and helping all students, regardless of race or family income. The foundation is headquartered in Seattle, Washington. | Financial Conglomerates | Corporate Officer/Principal | |
Orphinic Scientific SA
![]() Orphinic Scientific SA BiotechnologyHealth Technology Orphinic Scientific engages in the development and delivery of pharmaceutical drugs for the treatments of rare diseases. The firm also provides research and development services. The company was founded by and is headquartered in Rome, Italy. | Biotechnology | Founder | |
Vasa Therapeutics, Inc.
![]() Vasa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Vasa Therapeutics, Inc. is a private biotechnology company based in Encinitas, CA, committed to discovering and developing transformative therapies for vascular diseases such as heart failure, peripheral artery disease, and sarcopenia. The company's cutting-edge computational chemistry and design platform integrates everything from the identification of viable biological targets to the design and identification of small molecule or peptide therapeutics. Vasa has three active preclinical programs, two small molecule programs focused on the treatment of cardiovascular disease and one peptide therapeutic program aimed at identifying a novel treatment for peripheral artery disease and sarcopenia. The company has a world-class, founder-led team with an outstanding track record of successful development of numerous clinical candidates and commercial drugs spanning multiple therapeutic areas and modalities resulting in several exits values at greater than $1b (USD). The CEO of the company is Mark Robert Herbert. | Pharmaceuticals: Major | Chief Executive Officer |
Statistieken
Internationaal
Verenigde Staten | 4 |
Polen | 2 |
Sectoraal
Health Technology | 3 |
Commercial Services | 2 |
Finance | 2 |
Operationeel
Founder | 4 |
Director/Board Member | 3 |
Chief Executive Officer | 2 |
Chief Tech/Sci/R&D Officer | 2 |
Corporate Officer/Principal | 1 |
Sterkste connecties
Insiders | |
---|---|
Neil McDonnell | 3 |
Artur Plonowski | 3 |
- Beurs
- Insiders
- Keith Wycoff
- Bedrijfsconnecties